The applications you use to interpret and communicate molecular information are just as important as the tracers used to highlight that information and the technology used to capture it.

Quantitative applications allow you to prove what you see and, more importantly, prove what can’t be seen. They give you the assurance to determine the best course of treatment and the confidence to adapt treatment. They also give you the information to build a database of accurate results. Results that can be used to better inform the decisions you make for each patient and also, to inform the research that will develop more specific indications for disease.

Xeleris is our proven workstation dedicated to nuclear medicine. In the past, Xeleris led the way with mobilized applications that gave you accessible, easy-to-use tools to enhance productivity. Now, our latest version of Xeleris is leading the way with modern, quantitative applications for nuclear medicine; applications that help give you greater confidence of absolute quantitation in customizable, easy-to-read reports across multiple care areas.

A NEW ERA IN NUCLEAR MEDICINE

product-product-categories-nuclear-medicine-xeleris-xeleris 4-qbrain-image1.jpg

Accurately diagnose neurodegenerative diseases with Q.Brain

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image2.jpg

Diagnose pulmonary embolism by identifying V/Q mismatch with Q.Lung

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image3.jpg

Confidently classify patients eligible for lung resection surgeries with Q.Lung

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image4.jpg

Quantitate tracer uptake across any lesion or organ with Q.Metrix

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image5.jpg

Leverage the power of CZT to calculate blood flow measurements with Alcyone CFR

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image6.jpg

Improve neurologic SPECT workflow with fast, reproducible and accurate quantitation of I-123 loflupane SPECT data with DaTQUANT™

product-product-categories-nuclear-medicine-xeleris-xeleris 4-quantitation-image7.jpg

Plan radioisotope therapy by measuring changes in tracer absorption over time with Dosimetry Toolkit

¹In clinical practice, Evolution options^1a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit^1b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.

^1aEvolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT – SIMSET phantom followed by quantitative and qualitative images comparison.

^1bEvolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.

²Measurements compared to Infinia Hawkeye 4 with factory reference hybrid imaging scan conditions.

³Measurements compared to Infinia Hawkeye. Duration is measured according to effective scan time (e.g. transition movements are not considered), with the use of Evolution technology¹.